Sandostatin LAR Octreotide IM Injection








Endocrine and Pituitary News Letter
Receive "Endocrine &
Pituitary News Source"
by email weekly

Subscribe Today
Search
 
  A comprehensive approach to treating Acromegaly  
Sandostatin and Treating Acromegaly
  About Acromegaly  
Acromegaly is a rare and complex disease caused by overproduction of growth hormone.
 Diagnosing Acromegaly
 Treating Acromegaly
 
  The foundation in treating the symptoms of functional GEP NE Tumours  
Sandostatin and Treating GEP NE Tumours
  About GEP NE Tumours  
  Gastro-entero-pancreatic neuroendocrine (GEP NE) tumours are tumours that are located in the digestive tract.
   Diagnosing GEP NE       Tumours
 Treating GEP NE Tumours
 
Learn More

 Administering
    Sandostatin LAR


 Resources for Patients

 Our Newsletter
Recently Published Data
  The latest clinical research on:
Acromegaly
Endocrine
GEP NE Tumours
Pancreatic Surgery Complications
Esophageal Variceal Bleeding
Oncology
Clinical Trials of
Sandostatin LAR
Events
January 15-17, 2009
San Francisco, California

American Society of Clinical Oncologists - Gastrointestinal Cancers Symposium
(ASCO GI)

  more


1Scott-Levin's Physician Drug & Diagnosis Audit (PDDA) from Verispan, September 1996-August 2002.
2PubMed [database online]. National Center for Biotechnology Information. Available at: www.ncbi.nih.gov/gquery/gquery.fcgi?CMD. Accessed May 2003.